What core argument did Schultz and Campeau make in their 2020 Nature Chemistry think piece about academia-industry collaboration in drug development?

In their 2020 Nature Chemistry think piece, Schultz and Campeau argued that the divide between academic and industrial chemists holds back innovation in drug development, and that to increase the speed of translating fundamental chemical advances into new medicines, industrial scientists must actively engage with academics—collaborating closely and leveraging advanced industrial facilities to deliver practical solutions to key problems in drug development.

What specific collaborative model do Schultz and Campeau advocate to bridge the academia-industry gap in chemistry?

Schultz and Campeau advocate a collaborative model in which academics work much more closely with industry chemists, taking advantage of advanced industrial facilities to address and solve practical, high-impact problems in drug development—moving beyond theoretical or methodological exploration toward real-world application.

Pharm to Table Podcast Duo Bridges Academia-Industry Divide

Jun 9, 2026

Merck process chemists Dani Schultz and LC Campeau launched a podcast to bridge the gap between academic and industrial chemistry, aiming to accelerate drug development innovation through closer collaboration.

cen

2026-06-09

Pharm to Table Podcast Duo Bridges Academia-Industry Divide

FAQ

Scan to get the App